A metastatic spinal tumor reduces spinal support by destroying the vertebra and infiltrates and compresses the spinal cord and cauda equina, leading to pain, paralysis, and impairment of activities of daily living (ADL). In addition, most cases of metastatic spinal tumor result from a systemic disease with limited treatment. [1] [2] [3] [4] [5] Therefore, the main therapy is symptomatic treatment, and it is important to select a treatment that can reduce pain, improve paralysis, and maximize ADL as soon as possible under limited conditions. [1] [2] [3] [4] 6 Palliative posterior fixation is used in many cases. However, massive bleeding may occur during exposure of the surgical region or due to decompression and intratumor resection, and surgical stress for patients with cancer who have a limited life expectancy cannot be neglected. Therefore, performance of minimally invasive palliative posterior fixation is an important issue in patients with metastatic spinal tumor.
Minimally invasive palliative fixation using percutaneous pedicle screws (PPSs) for metastatic spinal tumor has been reported, [7] [8] [9] [10] [11] [12] but these studies have focused on surgical stress or short-term improvement of paralysis. Survival and evaluation of postoperative ADL have only been examined in a few reports. 4, 8, 10 In the current abstract
The goal of the study was to evaluate minimally invasive palliative surgery and the effect of postoperative adjuvant therapy for metastatic spinal tumor with a limited vital prognosis. Of the 70 patients who underwent palliative surgery for metastatic spinal tumor at the authors' hospital between March 2012 and May 2016, thirty-three were treated with minimally invasive spine stabilization (MISt) using percutaneous pedicle screws (PPSs) and included in the current study. Of the 33 patients, 26 were men and 7 were women; mean age at surgery was 68.6 years. Intraoperatively, posterior decompression and fusion was performed in 17 (51.5%) patients and fusion only was performed in 16 (48.5%). Mean operative time was 202.5 minutes, mean intraoperative blood loss was 331.6 mL, and intraoperative blood loss was 1500 mL or greater in 2 (6.1%) patients. Median postoperative survival time determined using the Kaplan-Meier method was 11.0 months (95% confidence interval, 7.3-14.6). 
Materials and Methods

Patient Population
The subjects were 70 patients who underwent palliative surgery for metastatic spinal tumor between March 2012 and May 2016. The criteria for minimally invasive spine stabilization (MISt) using PPSs were pain due to spinal instability, spinal cord paralysis, and radiation-resistant cancer.
The exclusion criteria were the possibility of cure and an indication for total en bloc spondylectomy, occipital over the cervical spinal lesions, difficulty in confirming the pedicle of the vertebral arch or PPS insertion under fluoroscopy, treatable with balloon kyphoplasty, treatable only with posterior decompression, predicted survival of less than 6 months with responsiveness to narcotic analgesics or a marked response to radiotherapy, and a poor systemic condition (Karnofsky's performance status 3 or higher) and reduced will to live. 2, 3, 5 The authors' decision for whether to operate was not decided by patients' life expectancy but rather by patients' clinical conditions, such as pain and paralysis.
Palliative surgery for metastatic spinal tumor was performed in 70 patients, of whom 33 met the indication criteria for MISt ( Table 1) . These patients included 26 men and 7 women; mean age at surgery was 68.6 years. The primary lesion was liver cancer in 10 patients, lung cancer in 6, thyroid cancer in 3, prostate cancer in 2, kidney cancer in 2, and gastric cancer in 2. The level of the main lesion was the thoracic vertebra in 20 and lumbar vertebra in 13. The Frankel classification 13 of preoperative paralysis was A in 1, B in 2, C in 8, D in 18, and E in 4. Preoperative visual analogue scale (VAS) score ranged from 1 to 10 (mean, 6.0).
The preoperative Tokuhashi score 2 for prognosis was 0 to 8 in 25 patients, 9 to 11 in 6, and 12 to 15 in 2; the mean score was 6.3. According to the Tokuhashi score, the survival period was predicted to be 6 months or less when the total score was 0 to 8, 6 months or greater when the total score was 9 to 11, and 1 year or greater when the total score was 12 or greater.
2
The spinal instability neoplastic score (SINS) 14 was 0 to 6 in 2 patients, 7 to 12 in 30, and 13 to 18 in 1; the mean score was 9.6. According to the SINS scoring system, 0 to 6 points indicates a stable spine, 7 to 12 points indicates potentially unstable spine, and 13 to 18 points indicates an unstable spine. 14 The epidural spinal cord compression (ESCC) scale 15 was grade 0 in 2 patients, 1a in 2, 1b in 1, 1c in 2, 2 in 14, and 3 in 12. According to the ESCC grading scale, a grade of 0 indicates bone-only disease; 1a, epidural impingement, without deformation of the thecal sac; 1b, deformation of the thecal sac, without spinal cord abutment; 1c, deformation of the thecal sac with spinal cord abutment, but without cord compression; 2, spinal cord compression, but with CSF visible around the cord; and 3, spinal cord compression, no CSF visible around the cord. 15 Mean preoperative Barthel Index 16 for ADL was 53.5. 
Surgical Technique
Surgery was performed with the patient in a prone position, enabling accurate imaging in frontal and lateral views by fluoroscopy on the operating table. The ES2 Spinal System (Stryker Spine, Kalamazoo, Michigan) was used for the PPS system. To insert a PPS, longitudinal skin incisions were made for the most cranial and caudal screw insertion regions, and transverse incisions were made for others, as a rule. When screws were inserted between multiple vertebrae, skin incisions were made in consideration of the rod arrangement (Figure 1 ). Screws were inserted into at least 2 vertebrae on the cranial side and 2 vertebrae on the caudal side of the lesion. When the rod did not interfere with application of decompression on the opposite side, decompression was applied after tightening rods on 1 side (Figure 2) .
Case examples are shown for a 71-year-old man with second lumbar vertebral and sacral metastases of prostate cancer who underwent posterior fusion (T12-iliac) and posterior decompression (L2) (Figure 3) .
Outcome Evaluation
The outcomes evaluated were postoperative survival, improvement of paralysis, operative time, intraoperative blood loss, incidence of complications, use of postoperative adjuvant therapy (chemotherapy, radiotherapy, and bone-modifying agent [BMA]), improvement of VAS, and discharge to home.
results
Parameters such as patients' Tokuhashi score, spinal instability neoplastic score, and epidural cord compression scale are shown in Table 1 . Intraoperatively, posterior decompression and fusion were performed in 17 (51.5%) patients and fusion only was performed in 16 (48.5%) ( Table  2) . Mean operative time was 202.5 minutes, mean intraoperative blood loss was 331.6 mL, and the mean number of fused vertebrae was 5.8. Intraoperative blood loss was 1500 mL or greater in 2 (6.1%) patients. One (3.0%) patient died within 30 days postoperatively.
Median postoperative survival time, calculated by the Kaplan-Meier method, was 11.0 months (95% confidence interval, 7.3-14.6) (Figure 4) . Regarding improvement of paralysis, the preoperative Frankel classification was C or lower in 11 (33.3%) patients, but this number decreased to 8 (24.2%) patients postoperatively ( Table 3) . Postoperatively, the classification was D in 7 (21.2%) patients and E in 18 (54.5%), and paralysis was aggravated in 1 (3.0%) patient. Neurological deficit was improved by at least 1 Frankel grade for 15 (45.5%) patients, and the number of ambulatory patients increased from 22 (66.7%) to 25 (75.8%) patients.
As postoperative adjuvant therapy, chemotherapy was performed in 17 (51.5%) patients, radiotherapy in 21 (63.6%), and BMA in 25 (75.8%) ( Table 4) . Mean VAS improved from 6.0 preoperatively to 0.8 postoperatively (P<.001). Mean Barthel Index for ADL improved from 53.5 preoperatively to 71.5 postoperatively (Figure 5) . Twenty-three (69.7%) patients were discharged to home.
discussion
The number of cancer survivors is increasing with advancement of cancer treatment, 17 and health-related quality of life (QOL) may be improved even in survivors of advanced cancer through palliative care. 18 Cases of symptomatic spinal metastasis have also increased because the survival time of patients with metastatic cancer has been extended, 1 and improved palliative care in these cases requires multidisciplinary treatment, including surgery. Prevention of spinal metastasis-induced skeletal-related events is one example of palliative care.
1 Skeletalrelated events have recently become better understood, and preventive treatment can be performed using BMAs, such as bisphosphonates, radiotherapy, and chemotherapy. Previous studies have focused on evaluation of the effect of surgery on metastatic spinal tumor, but improvement of outcomes by surgical treatment alone is limited. In the current study, the authors used a BMA (75%), radiotherapy (63%), and chemotherapy (51%) and found improvement of postoperative ADL in patients with metastatic spinal tumor. These results suggest that use of adjuvant therapies had a major influence on improvement of ADL.
It is difficult to predict the prognosis of metastatic spinal tumor. [2] [3] [4] [5] 19 Therefore, the significance of palliative surgery for patients with short predicted survival is uncertain. In the current patients, the mean Tokuhashi score was 6.3 and the score was 0 to 8 in 25 (75.8%) patients, indicating a life expectancy of less than 6 months. Palliative surgery in patients with a life expectancy of less than 6 months requires consideration for the risk of complications, the expected benefits, and the medical costs. 4, 19, 20 One viewpoint is that surgery should be performed because the potential improvement of ADL may increase opportunities for adjuvant therapy postoperatively, which indirectly is likely to prolong life. 21 This is supported by the findings in the current study, in which high rates of adjuvant therapies postoperatively prolonged survival by a median of 11.0 months compared with the predicted survival before surgery. The survival periods of the patients affect the prognosis such as Barthel Index. 5 Invasive palliative surgery for metastatic spinal tumor may aggravate the systemic condition of the patient, and therefore, minimally invasive palliative surgery has recently been examined. [7] [8] [9] [10] [11] [12] In the current study, mean operative time was 202.5 minutes and mean intraoperative blood loss was 331.6 mL, with massive intraoperative blood loss (≥1500 mL) in only 2 patients, indicating that the surgeries had sufficiently minimal invasiveness. The surgical procedure of these 2 cases was posterior decom- pression and stabilization with intralesional tumor resection. The surgical wound in posterior fusion using PPSs is small and rapidly heals, which is advantageous for administration of radiotherapy early postoperatively. On the other hand, posterior decompression and stabilization using PPSs with intralesional tumor resection was as invasive as conventional open surgery. It was one limitation of this procedure, and these results suggested that early detection and an early-stage treatment of spine metastases without intralesional tumor resection should be needed.
Previous studies of minimally invasive fixation as palliative surgery have mostly focused on technical points, whereas surgical stress, short-term improvement of paralysis, postoperative vital outcome, and the evaluation of postoperative ADL and QOL have only been described in a few reports. Improvement of QOL at 30 days postoperatively and a median postoperative survival time of 11.3 months have been reported. 8, 10 In the current study, median postoperative survival time was 11.0 months and mean Barthel Index for ADL improved to 71.5 postoperatively, although this improvement was a little more than that in the authors' previous study. 5 The current authors note that one limitation of the study is the absence of a detailed evaluation of QOL. However, the rate of discharge to home markedly increased to 69%, and treatment with a BMA, radiotherapy, or chemotherapy contributed significantly to improvement of QOL. One advantage of MISt is that it leaves a small surgical wound that rapidly heals. This allows early introduction of postoperative adjuvant therapy and a high rate of discharge to home, which then leads to improvement of QOL. In-hospital death 4 (12.1) 
